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Summary We compared an rK39 dipstick rapid test (Amrad ICT, Australia) with a direct agglutination test (DAT)
and splenic aspirate for the diagnosis of kala-azar in 77 patients. The study was carried out under ﬁeld
conditions in an endemic area of north-east Sudan. The sensitivity of the rK39 test compared with
splenic aspiration was 92% (46/50), the speciﬁcity 59% (16/27), and the positive predictive value 81%
(46/57). Compared with the diagnostic protocol used by Me ´decins sans Frontie `res, the sensitivity of the
rK39 test was 93% (50/54), the speciﬁcity 70% (16/23), and the positive predictive value 88% (50/57).
Compared with splenic aspirates, the sensitivity of a DAT with a titre ‡1:400 was 100% (50/50), but its
speciﬁcity only 55% (15/27) and the positive predictive value was 80% (50/62). Using a DAT titre
‡1:6400, the sensitivity was 84% (42/50), the speciﬁcity 85% (23/27) and the positive predictive value
91% (42/46). All four patients with DAT titre ‡1:6400 but negative splenic aspirate were also rK39
positive; we consider these are probably true cases of kala-azar, i.e. false negative aspirates, rather than
false DAT and rK39 seropositives. There were no false negative DATs (DAT titre £1:400 and aspirate
positive), but there were four false negative rK39 tests (rK39 negative and aspirate positive). The rK39
dipstick is a good screening test for kala-azar; but further development is required before it can replace
the DAT as a diagnostic test in endemic areas of the Sudan.
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Introduction
Visceral leishmaniasis (VL; kala-azar) is, ideally, diag-
nosed by demonstration of the parasite in spleen, bone
marrow or lymph node aspirates. In the endemic area of
north-east Sudan, splenic aspirates are more sensitive
(96%) than aspirates of bone marrow (70%) or lymph
nodes (58%) (Zijlstra et al. 1992). Over the last 13 years,
Me ´decins sans Frontie `res-Holland (MSF-H) has treated
approximately 43 000 cases of VL in Sudan, under harsh
ﬁeld conditions. The use of splenic aspirates in this setting
is limited, because of the small but deﬁnite risk of internal
bleeding, and the time and skill required in reading the
slides. Bone marrow and lymph node aspirates are safer
but less sensitive. Many patients would be denied life-
saving treatment on the basis of false-negative aspirates if
bone marrow or lymph node aspirations only were
performed. These characteristics make diagnostic aspir-
ation of any tissue unsuitable as a screening test for VL in
a ﬁeld setting.
Serological tests have been developed for VL, and the
direct agglutination test (DAT) is used in the Sudan (Harith
et al. 1986). DAT titres ‡1:3200 have been found to have a
sensitivity of 94% and a speciﬁcity of 72% (Zijlstra et al.
1992) for active disease. Lower titres are less speciﬁc
because of the high prevalence of antileishmanial anti-
bodies as a result of past infections in this Leishmania
donovani-endemic area. In 1991–93, an estimated 3.8–
4.8% of the population developed kala-azar annually, and
a further 2–3% had evidence of subclinical leishmaniasis
(Zijlstra et al. 1994).
When large numbers of patients are being assessed for
kala-azar, e.g. during epidemics, high DAT titres (‡1:6400)
plus a typical clinical picture (fever for >2 weeks, and
splenomegaly or wasting), may be used as a surrogate
method of diagnosing kala-azar without aspirations
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to antimonial treatment within 10 days conﬁrms the
diagnosis (WHO 1996). In addition, when the DAT titre is
very low ( £1:400) this effectively rules out kala-azar
(Boelaert et al. 1999). Thus the DAT can be used at high
titre as a diagnostic test, and at low titre as a screening test.
In this situation, if the patient has a DAT titre of >1:400
but <1:6400, aspirations are performed to conﬁrm a
diagnosis of leishmaniasis. MSF uses this diagnostic
protocol to reduce the number of aspirations (Veeken
1999).
The DAT, although speciﬁcally developed for the ﬁeld, is
still difﬁcult to use in remote conditions. First, antigen
production in specialized laboratories is laborious and
expensive. Secondly, it requires a cold chain of continuous
refrigeration; correct titre setting, cross checking with
controls, and meticulous implementation. Finally, the
method is time-consuming and requires considerable
training of the staff. Improvements have been made by the
introduction of freeze-dried antigen, replacing the unstable
aqueous antigen (Meredith et al. 1995). There is an urgent
need for a simpler, faster, non-invasive, but reliable test to
screen for, and/or to diagnose kala-azar in the ﬁeld.
Serological tests have been developed, using the cloned
antigen of 39 amino acid repeats of a kinesin like gene
found in L. chagasi, instead of whole Leishmania parasites.
Studies using the rK39 antigen, either in an ELISA (Badaro
et al. 1996) or dipstick form (Sundar et al. 1998), per-
formed well in Brazil, India and Europe (Badaro et al.
1996; Medrano et al. 1998; Ozensoy et al. 1998; Sundar
et al. 1998; Houghton et al. 1998). In Sudanese kala-azar
patients, a rK39-based ELISA was 93% sensitive, but only
80% speciﬁc (Zijlstra et al. 1998). We evaluated an rK39
dipstick test in the diagnosis of kala-azar, under epidemic
ﬁeld conditions in Sudan.
Methods
The evaluation was carried out in the MSF-Holland kala-
azar treatment centre at Um el Kher, Gedaref State, during
the months January and February, 1999. During these
2 months, 1093 patients were treated, and more than 2000
patients were screened for kala-azar. Patients with fever
and splenomegaly or wasting, were evaluated for kala-
azar. Alternative diagnoses in this region include malaria,
typhoid, and brucellosis. Patients were included in the
study if all the following results were available: frozen
serum stored at )20  C; splenic aspiration yielding
material of good quality; DAT performed. Suspects with a
positive spleen aspirate or a positive DAT (‡1:6400) were
treated for kala-azar, according to a protocol (WHO
1996). The spleen aspirates were examined by direct
microscopy after staining with Giemsa. One of the authors
(JS) checked all splenic aspirates and DAT titres, and
performed rK39 dipstick tests as speciﬁed by the manu-
facturer (Amrad ICT, PO Box 228, Brookdale, NSW 2100,
Australia).
We used the following deﬁnitions. Sensitivity: the
percentage of diseased with a positive test result (True
Positive/True Positive + False Negative). Speciﬁcity: the
percentage non-diseased with a negative test result (True
Negative/False Positive + True Negative). Positive Predic-
tive Value: the percentage of persons with a positive test
result, who truly have the disease (True Positive/True
Positive + False Positive). The protocol was internally
reviewed at MSF-H for ethical and scientiﬁc validity.
Results
The 77 patients being evaluated for kala-azar had a median
age of 11 years (range: 4–66); 41 were male; they had a
median spleen size of 2 cm below the costal margin (range:
1–4) and median haemoglobin of 8.7 g/dl (range: 4.5–13).
Of the 77 patients, 54 were treated for kala-azar according
to the MSF diagnostic protocol: 50/54 had a positive
splenic aspirate and 46/54 had a DAT titre ‡1:6400. The
results of the DAT compared with spleen aspiration are
shown in Table 1. The results of the rK39 dipstick test are
compared with spleen aspiration, DAT and the MSF
protocol in Tables 2–4, respectively.
The sensitivity of the rK39 test compared with splenic
aspiration was 92% (46/50; 95% CI: 81–98%), the specif-
icity 59% (16/27; 95% CI: 39–78%), the positive predictive
value 81% (46/57; 95% CI: 68–90%). Compared with the
diagnostic protocol used by MSF, the sensitivity of the rK39
test was 93% (50/54; 95% CI: 82–98%), the speciﬁcity
70% (16/23; 95% CI: 47–87%), and the positive predictive
value 88% (50/57; 95% CI: 76–95%).
Compared with splenic aspirates, the sensitivity of a
DAT with a titre ‡1:400 was 100% (50/50; 95%
CI: 93–100%), but its speciﬁcity only 55% (15/27; 95%
CI: 35–75%) and the positive predictive value was 80%
(50/62; 95% CI: 69–90%) (see Table 1). Using a DAT titre
Table 1 Results of the DAT compared with spleen aspirates of the
77 kala-azar suspects
DAT Aspirate+ Aspirate– Total
‡1:6400 42 4* 46
>1:400 and <1:6400 8 8 16
£ 1:400 0 15 15
Total 50* 27 77
* These 54 patients (50 + 4) were treated for kala-azar.
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93%), the speciﬁcity 85% (23/27; 95% CI: 66–96%) and
the positive predictive value 91% (42/46; 95% CI: 79–
98%). All four patients with DAT titre ‡1:6400 but neg-
ative splenic aspirate were also rK39 positive; we consider
these are probably true cases of kala-azar, i.e. false neg-
ative aspirates, rather than false DAT and rK39 seroposi-
tives. There were no false negative DATs (DAT titre
£1:400 and aspirate positive), but there were four false
negative rK39 tests (rK39 negative and aspirate positive).
Of the eight borderline DATs with a positive splenic
aspirate, seven also tested positive for rK39, whereas of the
eight borderline DATs with a negative splenic aspirate,
four tested positive for rK39. Of the 11 false positive rK39
tests, four had a borderline DAT test.
Discussion
The high sensitivity of the rK39 compared with MSF
diagnostic protocol (93%) means that it is a good screening
test for kala-azar in our hands. However, the advantage of
the DAT over the rK39 test is that titres ‡1:6400 also have
high speciﬁcity (85%) for kala-azar, so DAT can be used
for diagnosis as well as screening. It is worth emphasizing
that the positive predictive value (PPV) of DAT (or any
serological test for kala azar) is only high in circumstances
of high prevalence. If the prevalence of kala azar among
patients being tested were 15.6%, the PPV of DAT would
be only 29.5% and at a prevalence of 8.5%, the PPV of
DAT would be only 17.3%.
Unlike the DAT, the rK39 dipstick test is either positive
or negative – it lacks information on the strength of the
immune reaction. We consider it is important not to lose
this information by substituting the DAT with a dipstick.
False positive readings with the rK39 test were common in
this highly endemic area of Sudan, a ﬁnding not seen in
India (Sundar et al. 1998). Whether these false positive
tests could be caused by other endemic diseases such as
brucellosis and malaria remains to be investigated. Our
main interest was to see whether the test was useful under
the ﬁeld circumstances, where we have no means to
perform further serology. Its low speciﬁcity in relation to
splenic aspiration (59%) and to the diagnostic protocol for
kala-azar (70%) makes the rK39 test in its current form
unsuitable as a diagnostic test to replace the DAT, or
aspiration (or a combination of the two), under ﬁeld
conditions in Sudan. One should be cautious to extrapolate
the results of the study to other regions in the world, given
the different epidemic conditions. We suggest two ways in
which positive/negative rapid tests like the rK39 dipstick
might be used in a population with a high background
prevalence of antibodies to Leishmania. The ﬁrst method
would be to develop an rK39 test strip that gives a positive
reaction at low titre (for screening) and a separate test
indicating a high titre (for diagnosis). The second method
would be to use a highly sensitive dipstick test on neat and
serially diluted blood or serum samples, to determine the
titre of antibody in much the same way as is carried out
with the DAT at present.
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